Delivery Order SPE2DB24D3013-SPE2DB25FFFXQ

Award Date 10/24/24
Potential Completion Date 10/25/24
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,039.08 firm fixed-price contract is for the delivery of the specialty medication Repatha (Evolocumab) 140 mg/mL SureClick injector. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC...
This is a delivery order worth $14,758.88 awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The order is for the drug Repatha (evolocumab) 140 mg/mL SureClick. This appears to be part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare...
This is a Delivery Order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) under their Indefinite Delivery Contract (IDC) valued at $999,999,999. The contract is for the supply of Repatha (evolocumab) 140 mg/mL SureClick injectors, a specialty medication used for cardiovascular disease treatment. The Delivery Order has a firm fixed price of $1,016.82 and a completion date of September 25, 2024. There is no set-aside designation...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Repatha, a 140 mg/mL injectable medication, with a ceiling value of $5,824.85 and a period of performance through October 26, 2023. The contract was issued as a firm-fixed price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,193.09 delivery order contract is for the drug Repatha (evolocumab) 140 mg/mL SureClick, a specialty medication used to treat high cholesterol. The contract has a firm fixed-price pricing type and a period of performance through March 12, 2025. AmerisourceBergen holds a $999,999,999 Indefinite...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the major pharmaceutical distributor Amerisourcebergen Corporation, is for the delivery of Repatha, a 140 mg/mL medication, to the Defense Logistics Agency (DLA). The $2,352.63 firm fixed-price delivery order has a completion date of May 29, 2024. Amerisourcebergen holds two Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical and the Department of Justice Federal Bureau of Investigation, valued up...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Repatha, a specialty medication used to treat cardiovascular conditions, with a ceiling value of $1,845.45. It is a firm-fixed-price contract with an ultimate completion date of August 12, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,570.68 firm fixed-price delivery order is for the supply of Repatha 140 mg/mL SureClick medication. The contract has an ultimate completion date of December 9, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of Repatha, a specialty medication. The firm-fixed-price contract has a ceiling value of $1,016.82 and runs through November 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and expiring in November 2026, which serves as the primary vehicle for providing a...
This is a $38,715.92 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of Repatha (140 mg/mL SureClick) medication. The contract is not set aside and has an ultimate completion date of September 5, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a $999,999,999 IDC with the DLA Troop Support Medical through December 2025...
  • SPE2DB24D3013
    Indefinite Delivery Contract
  • SPE2DB24D3013-SPE2DB25FFFXQ
    Delivery Order

This is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order is for the specialty medication Repatha (evolocumab) 140 mg/mL, with a firm fixed price ceiling value of $1,525.23 and a completion date of October 25, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November 2026. The IDC covers a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific delivery order does not have a set-aside designation, indicating open competition. Amerisourcebergen's extensive federal contract awards and IDCs demonstrate its role as a key vendor for supplying essential medical commodities to various government agencies, particularly the DLA and Department of Justice Federal Bureau of Investigation, in support of military, veterans, and other federal healthcare programs.

Generated 1/23/25, 9:21 AM